(Q36740297)

English

HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy

scientific article published on 8 January 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1 reference

based on heuristic

inferred from title

cancer immunotherapy

1 reference

based on heuristic

inferred from title

Jean-Simon Diallo

object named as

Jean-Simon Diallo

4

0 references

object named as

Jonathan Pol

5

0 references

Jonathan L Bramson

object named as

Jonathan L Bramson

9

0 references

10

object named as

John C Bell

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Chantal G Lemay

3

object named as

Chantal G Lemay

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Brian Dennis Lichty

11

object named as

Brian D Lichty

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

author name string

Byram W Bridle

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Lan Chen

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Andrew Nguyen

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Alfredo Capretta

7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Rongqiao He

8

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Yonghong Wan

12

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

publication date

8 January 2013

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Molecular Therapy

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

21

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

887-894

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Histone deacetylases as regulators of inflammation and immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

HDAC inhibition and graft versus host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Potentiating cancer immunotherapy using an oncolytic virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Immunotherapy can reject intracranial tumor cells without damaging the brain despite sharing the target antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

FcRgamma activation regulates inflammation-associated squamous carcinogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

The many roles of histone deacetylases in development and physiology: implications for disease and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Immunotherapy of autoimmunity and cancer: the penalty for success

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Regulatory B cells as inhibitors of immune responses and inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

T-cell quality in memory and protection: implications for vaccine design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Histone deacetylase inhibitors as novel anti-inflammatory agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Positive and negative regulation of the innate antiviral response and beta interferon gene expression by deacetylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

VSV-tumor selective replication and protein translation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Recent progress in the battle between oncolytic viruses and tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Autoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other".

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

29 September 2017

Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

28 June 2018

Single-cell analysis of the human T regulatory population uncovers functional heterogeneity and instability within FOXP3+ cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

5 September 2018

MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

5 September 2018

Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

5 September 2018

Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

5 September 2018

Attrition of virus-specific memory CD8+ T cells during reconstitution of lymphopenic environments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

5 September 2018

Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

5 September 2018

Induction of anti-self-immunity to cure cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

5 September 2018

Involvement of interferon in virus-induced lymphopenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616544

5 September 2018

Autoimmunity and immunotherapy for cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of autoimmunity associated with tumor immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Down-modulation of responses to type I IFN upon T cell activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective Depletion of Nonspecific T Cells During the Early Stage of Immune Responses to Infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/MT.2012.265

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

release_ahsvt4pm3zhlbcciqbhblx3exa

1 reference

https://api.fatcat.wiki/v0/release/ahsvt4pm3zhlbcciqbhblx3exa

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36740297&oldid=1840542423"